ストックスクリーナーアプリを入手
0.87
0.45%
-0.0039
アフターアワーズ：
.88
0.01
+1.15%
前日終値:
$0.8739
開ける：
$0.8702
24時間の取引高:
52,784
Relative Volume:
0.48
時価総額：
$3.63M
収益：
-
当期純損益:
$-20.26M
株価収益率:
-0.1019
EPS:
-8.54
ネットキャッシュフロー:
$-8.25M
1週間 パフォーマンス:
+15.32%
1か月 パフォーマンス:
-1.53%
6か月 パフォーマンス:
-43.14%
1年 パフォーマンス:
-92.93%
1日の値動き範囲:
$0.8568
$0.91
1週間の範囲:
$0.735
$0.91
52週間の値動き範囲:
$0.735
$18.90
Oragenics Inc Stock (OGEN) Company Profile
名前
Oragenics Inc
セクター
電話
813-286-7900
住所
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
OGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGEN
Oragenics Inc
|
0.87 | 3.64M | 0 | -20.26M | -8.25M | -8.54 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Oragenics Inc (OGEN) 最新ニュース
Published on: 2026-01-07 07:41:25 - moha.gov.vn
Why analysts upgrade Oragenics Inc. stock2026 world cup usa national team quarterfinals defensive leaders set piece tactics tactical prediction analysis - Улправда
Is Oragenics Inc. stock vulnerable to rate hikesStock Market Trends & Outstanding Investment Returns - bollywoodhelpline.com
Certain Warrants of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Common Stock of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Certain Convertible Preferred Stock. of Oragenics, Inc. are subject to a Lock-Up Agreement Ending on 30-DEC-2025. - marketscreener.com
Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Outlook & High Return Stock Watch Alerts - Улправда
Aug Patterns: Why analysts upgrade Oragenics Inc. stockDollar Strength & Weekly Market Pulse Updates - Улправда
Growth Review: Can Oragenics Inc. stock beat market expectations this quarterJuly 2025 Trends & Free Community Consensus Stock Picks - moha.gov.vn
Momentum Shift: Is Oragenics Inc. stock resilient to inflationJuly 2025 Market Mood & Fast Gain Stock Tips - Улправда
Will Oragenics Inc. stock deliver shareholder valueWeekly Profit Report & High Return Trade Opportunity Guides - Улправда
Is Oragenics Inc. stock resilient to inflationJuly 2025 Summary & Verified Short-Term Plans - Улправда
Can Oragenics Inc. stock sustain revenue growthWeekly Market Report & Weekly Chart Analysis and Guides - DonanımHaber
Can Oragenics Inc. stock beat market expectations this quarterJuly 2025 Gainers & Free Expert Approved Momentum Trade Ideas - DonanımHaber
Will Oragenics Inc. stock reach all time highs in 2025Market Growth Summary & Daily Volume Surge Trade Alerts - Улправда
Is Oragenics Inc. stock trading at a premium valuationJuly 2025 Levels & Weekly High Potential Stock Alerts - Улправда
Aug Reactions: Is Oragenics Inc. stock trading at a premium valuationWeekly Trend Summary & Daily Chart Pattern Signal Reports - Улправда
Nasdaq Moves: Is Oragenics Inc. stock ideal for retirement investorsJuly 2025 Volume & Verified Technical Signals - Улправда
Earnings Miss: Will Oragenics Inc. stock reach all time highs in 2025 - Улправда
Oragenics (OGEN) CEO/CFO receives 250,000 stock options at $0.93 - Stock Titan
Oragenics (OGEN) reports immediate-vesting stock option grants to director - Stock Titan
Oragenics Adjusts Executive Compensation Plan - TipRanks
[Form 4] ORAGENICS INC Insider Trading Activity - Stock Titan
Oragenics (OGEN) discloses 125,000 director stock options grant - Stock Titan
Oragenics (OGEN) director granted 125,000 options at $0.93 exercise price - Stock Titan
Oragenics (OGEN) Awards Director 125,000 Stock Options at $0.93 Exercise Price - Stock Titan
Dir Telling Files To Sell 210 Of Oragenics Inc [OGEN] - TradingView — Track All Markets
OGEN (OGEN) holder files Form 144 to sell 210 common shares - Stock Titan
Oragenics (NYSEAMERICAN:OGEN) Shares Down 1.5% – What’s Next? - Defense World
Why Oragenics Inc. stock attracts wealthy investorsAnalyst Upgrade & Consistent Profit Focused Trading Strategies - Newser
Will Oragenics Inc. stock benefit from infrastructure billJuly 2025 Market Mood & Weekly Momentum Picks - Newser
Is Oragenics Inc. stock attractive post correctionJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser
Why Oragenics Inc. stock is a strong buy callJuly 2025 Review & Accurate Intraday Trade Tips - Newser
Downgrade Watch: Can Oragenics Inc stock deliver 10 annual returnsQuarterly Trade Summary & Daily Profit Focused Stock Screening - BỘ NỘI VỤ
Can Oragenics Inc. stock hit record highs againWeekly Stock Analysis & Smart Investment Allocation Insights - Newser
Will Oragenics Inc. stock hit Wall Street targets2025 Top Gainers & Short-Term Trading Opportunity Alerts - BỘ NỘI VỤ
Oragenics Inc. (OGEN) 5.26% in After-hours: What’s Driving the Move? - Stocks Telegraph
Preferred dividends of Oragenics, Inc. – MUN:UAV0 - TradingView
Can Oragenics Inc. stock resist broad market declinesQuarterly Profit Report & AI Optimized Trade Strategies - newser.com
Will Oragenics Inc. stock see valuation expansionMarket Performance Recap & Stock Timing and Entry Methods - newser.com
How Oragenics Inc. stock performs in interest rate cycles2025 Growth vs Value & Daily Momentum Trading Reports - newser.com
Combining machine learning predictions for Oragenics Inc.Market Trend Summary & Fast Momentum Stock Entry Tips - newser.com
Will Oragenics Inc. stock benefit from infrastructure spendingQuarterly Profit Summary & Fast Momentum Entry Tips - newser.com
Will Oragenics Inc. stock maintain momentum in 2025Weekly Trade Report & Verified Chart Pattern Signals - newser.com
Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN
What technical charts say about Oragenics Inc. stock2025 Retail Activity & Weekly High Return Stock Opportunities - newser.com
Oragenics Inc. stock outlook for YEARQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Oragenics Inc (OGEN) 財務データ
収益
当期純利益
現金流量
EPS
2.52%
0.07%
大文字化:
|
ボリューム (24 時間):